Quick search
45 search result for "Alcohol"
09.06.2026
JA PreventNCD General Assembly
The 2026 General Assembly will kick off with a one-day plenary on June 9th highlighting our shared project achievements to date and setting an inspiring tone for the days ahead. On June 10th and 11th, we’ll dive into hands-on workshops, aiming to present insights, exciting results and experiences from activities and pilots within JA PreventNCD, piecing together how the various efforts contribute to the overall objectives of the project. We’ve also set aside dedicated time for WP-specific meetings, ensuring every team’s unique contributions are recognized and advanced. Our event will end in a joint plenary session on June 11th, bringing everyone together to celebrate progress and chart the course ahead. The overall aim of the General Assembly is to contribute to the consortium being able to deliver on the overall objectives of JA PreventNCD: improve joint capacities of MSs to plan and implement prevention policies and activities at national, regional, and local levels improve the monitoring system for NCDs and their common risk factors contribute to reduced inequalities in NCDs engage with key actors in the field of NCD prevention, including decision makers, civil society organizations, professionals, the general population, and patients’ groups to facilitate cooperation and joint efforts. Purpose and expected outcomes of the General Assembly 2026 By June 2026, we are more than halfway into the project. Thus, the purpose of this event is to further drive inspiration and collaboration among project participants, promote high scientific quality and relevance of our work, facilitate effective collaboration within the project, and to ensure project coherence and common understanding of project objectives. The event will also aim to facilitate open discussions on our work, including challenges and opportunities as we start to plan for the final outcomes of the project. Meeting in person is especially valuable, as it allows for building stronger relationships, exchanging ideas more freely, and fully engaging in networking opportunities that can spark new synergies and enhance the overall impact of our joint efforts. Specifically, the goal is to: Present and reflect on key results: share experiences and lessons learned to strengthen effective implementation Joint action – added value: Enhance the added value of joint action by strengthening collaboration across countries, work packages, and partners, and by aligning on the project’s key achievements and dissemination activities Way forward: Provide a setting for inspiration and critical reflection regarding the remainder of the project, including exploitation and uptake of results and sustainability. Clear outcomes will be defined, individual results integrated into the project narrative, and sustainability embedded into actions and deliverables. Topics to be included At this meeting we really aim to present progress from our exciting results and experience from ongoing activities and pilots from JA PreventNCD. We will also invite representatives from MSs and experts to comment and provide feedback on the work presented. Since the last general assembly in Katowice, the European Union has launched the Cardiovascular Health plan. JA PreventNCD has a number of important activities supporting this plan, and such activities will be highlighted. The program is not yet finalized, but the following topics are being discussed as part of plenary and/or parallel sessions: Presentations on project outputs and success stories Key achievements Cross-cutting themes on risk factors: Alcohol, Physical inactivity, Nutrition and Tobacco Financial management and reporting Who should attend? This meeting is open to all partners of the JA PreventNCD consortium, Competent Authorities, Affiliated Entities and Associated Partners. Invitations are in particular directed at, but not limited to, colleagues with a leading role in tasks, subtasks, pilots or other key activities such as reporting. Invitations are also extended to: Members of our External Expert Advisory Board, Members of our Youth Advisory Group Thematic Coordinators Members of the Data Management Board, the Ethics Board and the Publication Board Project observers Other synergistic EU granted projects Please remember that the cost of participation is the responsibility of your own institution, and we advise you to also confer with your respective (sub/task) leads. Registration Registration details have been shared directly with the consortium and relevant stakeholders. If you believe you should have received an invitation but have not yet received one, please contact [email protected]. The registration deadline for in-person attendance is now closed. Registrations for online attendance remain open until May 29. Practical information The General Assembly will take place at the Istituto Superiore di Sanità (ISS), Viale Regina Elena 299, 00161 Rome, Italy. Rome is a major European hub and is well connected by air and rail, with frequent international connections and extensive local public transport options. How to reach the venue By public transport The venue is located in the Nomentano / San Lorenzo area and can be reached by Rome’s public transport network. The Policlinico metro station (Line B) is nearby, with onward connections across the city. By train Rome’s main rail hubs connect the city with destinations across Italy and Europe. From central stations, the venue area can be reached via metro, tram/bus, or taxi. By plane Rome is served by two international airports (Fiumicino – Leonardo da Vinci and Ciampino) with frequent connections to European cities. Further details, including recommended accommodation options and additional local guidance, will be shared closer to the event once the programme and logistics are finalised. The programme for the event is available here.
https://www.preventncd.eu/events/meeting/ja-preventncd-general-assembly/
12.11.2025
European Public Health Conference 2025 JA PreventNCD
JA PreventNCD will this year have strong representation from its members at the European Public Health Conference 2025 (EPH Conference) in Helsinki, Finland, taking place from 11–14 November. The conference brings together thousands of professionals from across Europe to exchange knowledge, inspire collaboration, and strengthen the public health community. JA PreventNCD’s participation highlights the project’s commitment to advancing policy, research, and action on the prevention of noncommunicable diseases (NCDs) across Europe. Throughout the week, JA PreventNCD members will share insights on policy alignment, health equity, tobacco control, sustainable diets, and health taxation, all key to building healthier and fairer societies. Learn more about the conference: https://ephconference.eu Pre-Conference Session Policies supporting NCD prevention at regional, national and local levels – effective, aligned and equitable? Tuesday 11 November, 13:30–17:00 (network lunch from 12:30) Organised by Joint Action PreventNCD You can find the programme details by clicking here. This pre-conference explores how policies across Europe can better prevent noncommunicable diseases by examining evidence and examples from different governance levels. It brings together experts from the European Commission, WHO, UNICEF, academia, and JA PreventNCD partners to discuss successes and challenges in creating effective, aligned, and equitable policies. The session will cover topics such as the forthcoming European Commission Plan for Cardiovascular Health, the role of tobacco control legislation, food system transformation for healthier and more sustainable diets, and the impact of health taxation and alcohol warning labels on health inequalities. Partners will also present findings from policy mapping across 17 countries, experiences in public food procurement for healthier food environments, and approaches to local public health action, including lessons from the Norwegian Public Health Act. The pre-conference will conclude with a high-level panel discussion featuring public health officials, academics, and youth representatives on future directions and implications for health and equity. Audience participation will be encouraged throughout the session. Participants already registered to the main conference can join the session by emailing [email protected]. Workshops Featuring JA PreventNCD JA PreventNCD will also be well represented throughout the main conference, with several workshops led or co-hosted by project partners between 12 and 14 November. Date Time Title 12 Nov 16:45 – 17:45 Please mind the gaps: toward harmonization of Europe’s noncommunicable disease monitoring systems 13 Nov 15:15 – 15:40 Reducing Health Inequalities in Europe: From Data to Policy and Action 13 Nov 16:45 – 17:45 How could countries with joint implementation actions assure sustainability of public health outcomes? The case of JA PreventNCD 13 Nov 16:45 – 17:45 Health Literacy in Action: Innovative and Inclusive Approaches from European Joint Initiatives (JA PreventNCD / JACARDI) 14 Nov 11:45 – 12:45 Public health dashboards and health inequality monitoring in Europe Follow the Action There is a lot happening during this week, and we will be sharing it all!Follow JA PreventNCD on LinkedIn and Facebook for daily highlights, key insights, and updates from Helsinki.Join the conversation and show your support using #JAPreventNCD #EPH2025 #EU4Health #PublicHealth
https://www.preventncd.eu/events/conference/european-public-health-conference-2025-ja-preventncd/
26.09.2025
Health Taxes and NCD Prevention
Health taxes are generally defined as fiscal instruments designed to promote public health. Such taxes primarily target the consumption of products with harmful health effects, including tobacco, alcohol, and some foods products. While the primary objective of health taxes is to influence consumption patterns, they also generate government revenue, which can be used to offset healthcare costs arising from the consumption of unhealthy commodities. In the forthcoming webinar we aim to examine the concept of health taxation in greater depth, addressing two central questions: what constitutes health taxation, and what are the benefits and challenges? Particular attention will be devoted to the ways in which European member states can employ health taxation as a policy tool. The webinar will feature Professor Franco Sassi who is currently Chair of International Health Policy and Economics and Director of the Centre for Health Economics & Policy Innovation at Imperial College Business School. Professor Sassi has been contracted by the JA PreventNCD to lead the work on Health Taxation and will give an introduction to health taxes. Michele Cecchini, who is responsible for the OECD programme of work on Public Health, will present perspectives on the health and economic dividends of health taxes. Finally, Oliver Gainford from the Directorate-General for Taxation and Customs Union (DG TAXUD), will provide the perspectives from DG TAXUD on the use of health taxes in the European member states. The webinar will be moderated by Arnfinn Helleve from the Norwegian Institute of Public Health, who serves as leader of Work Package on Regulation and Taxation in JA PreventNCD. This webinar is relevant to policymakers, civil society organizations, and academic stakeholders engaged in public health. Join us in this JA PreventNCD webinar and register here.
https://www.preventncd.eu/events/webinar/health-taxes-and-ncd-prevention/
10.10.2025
Communicating for Impact: Changing Health Narratives Together
Co-hosted by WHO/Europe, JA PreventNCD, and JACARDI, this high-level communications event will explore how to strengthen public health messaging in the attention economy and build trust in health narratives. The day will feature: Keynote talks on media strategies and the attention economy. A fishbowl session on trust, equity, and responsibility in health communications. Evidence-based messaging sessions focusing on alcohol, tobacco, physical activity, and nutrition. A screening of Unmasking Influence, a documentary on commercial determinants of health, followed by discussion. Workshops on campaign creation, including message testing, user insights, and social listening. The event will bring together policymakers, communication experts, researchers, youth representatives, and public health professionals from across Europe. Please note: Participation is by invitation only.
https://www.preventncd.eu/events/workshops/communicating-for-impact-changing-health-narratives-together/
16.06.2025
2025 Annual Meeting
The Annual JA PreventNCD Meeting 2025 will take place from 16–17 June 2025 at the International Congress Centre (MCK) in Katowice, Poland. This event brings together partners, invited experts, and representatives from European institutions to share progress, strengthen collaboration, and address key public health challenges in the prevention of non-communicable diseases (NCDs). In parallel, the meeting will partly overlap with the 2nd Meeting of the Consortium on Cancer and other NCDs Prevention (EU-CNCD). A detailed description of the scope and purpose of the meeting is available for download here (PDF). See the preliminary agenda below for full details of the program. Deadline for registration for the meeting is: In-person: 25th of April 2025 Online: 9th of June 2025
https://www.preventncd.eu/events/meeting/2025-annual-meeting/
21.11.2024
OECD Webinar on "Tackling the Impact of Cancer on Health, the Economy and Society"
The OECD will be launching the “Tackling the Impact of Cancer on Health, the Economy and Society” report on 21 November 2024 at 13:00-14:30 CET (Paris time). Cancer causes one in four premature deaths in OECD countries, and accounts for 10% of healthcare expenditure. But its impacts extend beyond the health system. Cancer negatively affects people’s mental health, work life and income. At a societal level, cancer reduces workforce performance and productivity. Using microsimulation modelling, this report shows how stronger action on cancer would yield broad benefits in 51 countries (including OECD, European Union and G20 countries). Reducing the variability in cancer care outcomes across countries could prevent a quarter of premature cancer deaths. Addressing key cancer risk factors, including tobacco, alcohol, unhealthy diet, air quality, overweight and physical inactivity, would not only lower cancer rates and health expenditure, it would also benefit the labour market, safety and the environment. Vaccination for human papilloma virus can protect future generations from cervical cancer. The report demonstrates that there is a strong economic and societal well-being case for investing in cancer policies. The agenda for the launch event is as follows: 21st of November 2024 13:00-13:05: Welcome and opening remarks 13:05-13:25: Presentation of the OECD report 13:25-13:40: Q&A with the audience and interventions 13:40-14:25: Panel discussion with the following confirmed speakers to discuss policy priorities to tackle cancer: US National Cancer Institute - Ophira Ginsburg (Senior Scientific Advisor for Clinical Research) EU JA PreventNCD - Knut Inge Klepp (Special Advisor, Norwegian Institute of Public Health and coordinator of the JA) Cancer Research UK – Ian Walker (Executive Director) UICC - Ulrika Årehed Kågström (President) 14:25-14:30 – closing remarks and end of the webinar To learn about the findings from the report, as well as how countries are moving forward to improve the quality of care for cancer and invest on prevention, please register at this link. For further information about this webinar, please contact: [email protected] or [email protected].
https://www.preventncd.eu/events/webinar/oecd-webinar-on-tackling-the-impact-of-cancer-on-health-the-economy-and-society/
29.10.2024
Commercial Determinants of Health - The Impact On Public Policy Making
This webinar highlighted the significant role of the commercial sector in influencing the prevalence of non-communicable diseases (NCDs) and cancers through its practices, products, and systems. It raised awareness about strategies employed by commercial entities to influence public policy-making and proposed potential strategies for policymakers to prevent commercial interests from undermining policies designed to improve public health and well-being. During the session, Professor Anna Gilmore from the University of Bath introduced the concept of the commercial determinants of health. Professor Karine Gallopel-Morvan from the National Institute of Health and Medical Research in France provided specific examples of how the alcohol industry has resisted health warning labels on alcoholic products. Sara Cerdas, former Member of the European Parliament, discussed how commercial actors have sought to influence European policy-making processes and proposed strategies to mitigate their impact. The webinar was moderated by Arnfinn Helleve from the Norwegian Institute of Public Health, leader of the joint work package on Regulation and Taxation in JA PreventNCD. This session was particularly relevant to policymakers, civil society organizations, and academia. You can view the recording below.
https://www.preventncd.eu/events/webinar/commercial-determinants-of-health-the-impact-on-public-policy-making/